Johnson & Johnson

NYSE:JNJ   3:59:57 PM EDT
163.38
-0.40 (-0.24%)
5:20:21 PM EDT: $162.91 -0.47 (-0.29%)
Products, Regulatory

EMA Approves Additional Manufacturing Site In Pennsylvania For Vaccine Janssen

Published: 10/07/2021 12:41 GMT
Johnson & Johnson (JNJ) - Ema: Additional Manufacturing Site for Covid-19 Vaccine Janssen: 07/10/2021.
Ema: Approved an Additional Manufacturing Site for the Production of Covid-19 Vaccine Janssen, Developed by Janssen-cilag International Nv.
Ema - the Site, Located in West Point, Pennsylvania in the United States, and Operated by Merck Sharp & Dohme Corp, Will Manufacture Finished Product.
Ema: Recommendation Does Not Require a European Commission Decision and Thus the Site Can Become Operational Immediately.
Ema Says Site is Expected to Support Continued Supply of Covid-19 Vaccine Janssen in European Union.
.
((reuters.
Briefs@thomsonreuters.
Com;)).